123707 Apr 2026

The law provides this unit with extraordinary flexibility because the stakes are so high. According to the statute:

: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment. 123707

: Because cases of infant botulism can fluctuate by up to 60% annually , any unspent funds at the end of a fiscal year are automatically carried forward. This "rainy day" provision ensures that when an outbreak occurs, the resources are already in place. The law provides this unit with extraordinary flexibility

Below is a feature article written about this unit and its critical mission. This "rainy day" provision ensures that when an

Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®.

The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants.

The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit